Trend-Following Backtester · Guide · backtest 한국어

equity · DE

Dermapharm Holding SE backtest

10 trend-following strategies were compared on the full daily history of Dermapharm Holding SE. 8 beat buy-and-hold CAGR; Supertrend ranks first by Sharpe, matching the main backtester. The return/drawdown alternative is Keltner 채널 돌파 (CAGR 8.2%, MDD -26.4%).

Data 2018-04-12 ~ 2026-07-31daily bars 2,109 (8.3 years)Costs 0.5%Venue XETRMonthly snapshot 2026-07-31

Results by strategy

8 of 10 beat buy and hold (CAGR 5.1%, drawdown -66.6%).

Sharpe leader (same as main): Supertrend — CAGR 11.1%, MDD -30.5%, Sharpe 0.58, 55% exposure.

Return/drawdown alternative: Keltner 채널 돌파 — CAGR is 6.0%p higher than buy and hold, while drawdown improves by 36.2%p (CAGR 8.2%, MDD -26.4%, exposure 33%).

The alternative must retain 75% of buy-and-hold CAGR, improve drawdown by at least 20% and 5 percentage points, and stay below 95% exposure; the ranking weights return retention 60% and drawdown improvement 40%.

Strategy · parametersCAGRMDDSharpeCalmarTotalTradesExposure
Supertrend
period=24, mult=3.8
11.1%-30.5%0.580.362.4x3455%
Keltner 채널 돌파
emaPeriod=31, atrPeriod=15, mult=2
8.2%-26.4%0.510.311.9x4233%
EMA 크로스오버
fast=51, slow=143
9.8%-44.1%0.510.222.2x753%
SMA 크로스오버
fast=48, slow=175
9.4%-44.2%0.490.212.1x753%
ADX / DI 방향성
period=38, threshold=10
8.1%-51.4%0.460.161.9x5851%
볼린저 밴드 돌파
n=46, k=1
6.0%-29.7%0.390.201.6x5441%
Parabolic SAR
step=0.005, maxStep=0.24
6.1%-41.6%0.370.151.6x7247%
ROC 모멘텀
n=140, threshold=-0.03
6.3%-41.3%0.370.151.7x4759%
Donchian 채널 돌파
entryN=21, exitN=73
4.4%-42.9%0.300.101.4x2175%
MACD
fast=16, slow=55, signal=20
1.6%-44.7%0.180.041.1x8048%
Buy and hold5.1%-66.6%0.320.081.5x1100%
1x 2019 2020 2021 2022 2023 2024 2025 2026 SupertrendBuy and hold
Supertrend: Solid strategy line versus dashed buy-and-hold line. Log scale.
0% -17% -33% -50% -67% 2019 2020 2021 2022 2023 2024 2025 2026 Buy and holdSupertrend
Supertrend maximum drawdown -30.5% (2021-11-03 → 2024-08-05), recovered after 1,653 days.

Rules of the top strategy

Trades the direction of a volatility-based trend line that trails below/above price.

Method and caveats

Past performance does not guarantee future returns. Parameters were selected on the same full-history sample using sharpe over 40 trials per strategy, so results contain in-sample bias. 0.5% trading costs are included; taxes, slippage and rejected orders are not.
Re-run the same setupAll asset reports

Read next